home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences

Search

 
  Genetic & Cell Therapies in Cardiovascular Disease  
  January 28, 2003

Cardiovascular Research

 
     
  Mayo Clinic, Rochester, MN
October 24 - 26, 2003


This course aims to explore the advances of cell and gene therapies for cardiovascular diseases. Currently, many opportunities exist for the use of these novel approaches to treat patients with cardiovascular disease. This course will provide information regarding advances in preclinical and clincal studies of gene transfer. Areas of opportunities as well as challenges will be discussed in full and the relevance will be to trainees as well as to practicing physicians and scientists. The use of autologous cell based therapy for cardiovascular diseases has been recently established. The comparisons between the types of cells that might be available as well as their therapeutic potential will be discussed. Advances in preclinical studies using these cells will be fully explored.
 
 
Organized by: Robert Simari, M.D. and Noel Caplice, M.D.
Invited Speakers: Stefanie Dimmeler, M.D.
Robert P. Hebbel, M.D.
Jan Rozing, M.D.
Michael D. Schneider, M.D.
Catherine M. Verfaillie, M.D.
Andreas M. Zeiher, M.D.
Keith March, M.D., Ph.D.
Eduardo Marban, M.D.
Walter Koch, Ph.D.
Edith Tzeng, M.D.
 
Deadline for Abstracts: August 1, 2003
 
Registration: Mayo Clinic Cardiovascular CME 200 First Street SW - GO-06-138SW Rochester, MN 55905 P: 507-266-0677 or 1-800-283-6296 F: 507-538-0146
E-mail: CVCME@mayo.edu
 
  Posted by:   Deborah Feils  
Host: cache1.mayo.edu
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.